![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 27, 20235-20238, July 7, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
and
§¶
From the
Department of Pathology, Anatomy and Cell
Biology, and § Program in Cell Biology, Kimmel Cancer
Center, Jefferson Medical College, Thomas Jefferson University,
Philadelphia, Pennsylvania 19107
Received for publication, March 30, 2000, and in revised form, May 2, 2000
| |
ABSTRACT |
|---|
|
|
|---|
Bamacan can occur in certain cell types as either
a secreted proteoglycan assembled into basement membranes or as an
intracellular protein known as structural maintenance of chromosome 3 (SMC3). To assess the role of this protein in tumorigenesis, we
investigated whether induced overexpression of bamacan/SMC3 could
transform normal fibroblasts. We generated a full-length cDNA
encoding the entire mouse bamacan/SMC3 and demonstrated appropriate
transcription and translation into a 146-kDa protein. All the NIH and
Balb/c 3T3 murine fibroblasts overexpressing this bamacan/SMC3
transgene generated foci of transformation and acquired
anchorage-independent growth. The increased levels of bamacan/SMC3
expression achieved in the transfected fibroblasts were the same as
those detected in a series of spontaneously transformed murine and
human colon carcinoma cells. Moreover, a 3-4-fold overexpression of
bamacan/SMC3 was detected in ~70% of human colon carcinoma specimens
from matched pairs (n = 19, p < 0.0002) and in a cohort of intestinal tumors from
Apc-deficient Min/+ mice. These results support
the concept that deregulated expression of bamacan/SMC3 is involved in
cell transformation.
Originally isolated from the embryonic parietal yolk sac as a high
density chondroitin sulfate proteoglycan (1, 2), bamacan was
subsequently identified to be a component of the renal mesangial matrix
(3), the basement membrane of other tissues (4), and tumor matrix (5).
The murine protein is encoded by 31 exons distributed along ~45
kilobase pairs of genomic DNA (6) and is highly conserved across
species (7-9). Secondary structure analysis of the protein reveals
three globular domains intercalated by two We previously detected increased bamacan/SMC3 mRNA levels in
several transformed cell lines (6), suggesting that the amplified product of the normal gene may play a role in tumorigenesis. To directly test this hypothesis we investigated the effects of transgenic overexpression of bamacan/SMC3 in NIH and Balb/c 3T3 mouse fibroblasts. All the cells overexpressing bamacan/SMC3 showed evidence of
transformation, including anchorage-independent growth and foci of
transformation. Moreover, all the stably transfected clones exhibited
increased levels of bamacan/SMC3 identical to those of spontaneously
transformed human colon carcinoma cell lines and colon cancer
specimens, as well as intestinal tumors from Apc-deficient
Min/+ mice. Thus, deregulated expression of bamacan/SMC3 may
be directly linked to the complex process of oncogenesis.
Materials and Cells--
[ Generation of Full-length Bamacan cDNA and Expression
Vectors--
Full-length bamacan cDNA was assembled by sequential
ligation of EST clones AA144255, AA164123, and AA119169 and of a
cDNA fragment generated by reverse transcriptase polymerase chain
reaction (RT-PCR). Because of the lack of suitable subcloning vectors,
one was generated from pBS-KS+ by replacement of the multiple cloning
site between the KpnI and the NotI with a 24-bp oligonucleotide corresponding to the restriction sites KpnI,
SpeI, XhoI, NcoI, SalI,
NotI (5' to 3'). These new sites allowed the sequential
subcloning of the various cDNAs. The coding region of bamacan/SMC3
was inserted at the NotI/EcoRV sites of the
pcDNA3.1 myc-His (Invitrogen). A pLXSN retroviral expression vector
(CLONTECH) was also constructed. All ligations were
verified by restriction map digestion and DNA sequencing.
Stable Transfection, Tumorigenic Assays, and Northern and Western
Blotting--
Balb/c 3T3 cells were transfected with 50 µg of
expression vector by electroporation (230 V, 1080 microfarads/s). After
2 days, G418 (250 µg/ml) was added and drug selection carried out for
2 weeks. Single colonies were ring-cloned and expanded. Ten days later,
RNA was extracted from a first group of cells whereas the parallel
group was fixed in 70% ethanol, stained with 0.2% methylene blue, and
analyzed for the presence of foci of transformation. Growth in soft
agar and colony formation was determined by culturing 3 × 103 cells between two layers of 0.4% (bottom) and 0.2%
(top) agar solution. Colony size was scored at 14 and 21 days by
counting the number of cell aggregates >100 µm diameter in several
randomly selected 9-mm2 areas. Bamacan mRNA levels were
assessed by Northern blotting as described previously (6). Cellular
levels of bamacan/SMC3 were assessed by Western immunoblotting.
Briefly, the cells were solubilized in phosphate-buffered saline
containing 0.1% Triton X-100 and a mixture of protease inhibitors
CompleteTM (Roche Molecular Biochemicals), separated by
SDS-PAGE, and immunoblotted using the primary antibody at 1:300
dilution and the secondary (peroxidase-conjugated anti-rabbit IgG) at
1:17,000 dilution, followed by chemiluminescence (Pierce) detection.
Generation of an Expression Vector Encoding the Full-length
Bamacan/SMC3 cDNA and in Vitro Transcription/Translation--
To
assess the role of bamacan in tumorigenesis, we first needed to
construct a full-length eukaryotic expression vector. The strategy for
the assembly of full-length mouse bamacan/SMC3 cDNA, and the
pcDNA3.1 and retroviral pLXSN expression vectors, is illustrated in
Fig. 1, A and B.
The full-length cDNA encompasses 3672 bp and encodes 1206 amino
acid residues, including a C-terminal stretch of 11 residues that are
not present in the rat sequence (7). To assess whether the predicted
open reading frame of the bamacan/SMC3 cDNA could be translated
into a protein, the pcDNA3.1 vector was tested in a rabbit
reticulocyte lysate transcription-translation system using
[35S]methionine as the precursor. The results showed a
single protein of the expected size of ~146 kDa (Fig. 1C,
lanes 1 and 3). Lack of the expression vector in
the reaction mixture generated no detectable protein (Fig.
1C, lane 2), whereas addition of the vector
encoding luciferase gave the predicted band of ~60 kDa (Fig.
1C, lane 4). Thus, the full-length cDNA
encoding bamacan protein is appropriately transcribed and translated
into a protein of size (146 kDa) identical to the native
bamacan/SMC3.
Overexpression of Bamacan/SMC3 Causes Transformation of Normal
Murine Cells--
Because bamacan mRNA levels are elevated in a
number of tumorigenic cell lines (6), we investigated whether
overexpression of this protein could directly produce cell
transformation. For this purpose, normal NIH and Balb/c 3T3
fibroblasts, which are both contact inhibited, were transfected with
the pcDNA3.1 bamacan/SMC3 expression vector. Of the 22 clones
obtained, 3 displayed ~4-fold bamacan overexpression (Fig.
2A). Eighteen of these clones
were tested for the ability to generate colonies in soft agar. In these experiments, clones 9 and 22, i.e. those overexpressing
bamacan mRNA, displayed anchorage-independent growth and generated
31 ± 4 (n = 3) and 23 ± 4 (n = 4) colonies >100 µm diameter after 3 weeks of
growth (Fig. 2B). No colonies were observed in the remaining
16 G418-resistant clones expressing normal bamacan mRNA and in wild
type cells. Growth kinetics experiments revealed that the
overexpressing clones had lost contact inhibition, confirming they had
acquired a transformed phenotype. Initial growth rate did not differ
significantly between overexpressing and normally expressing bamacan
clones. However, upon reaching confluence, normally expressing clones
significantly reduced their duplication rate to ~0.2 doubling/day,
whereas clones 9 and 22 maintained a vigorous duplication activity
(~0.6-1 doubling/day) (Fig. 2C). All the G418-resistant
clones were tested in a transformation focus assay. Whereas wild type
and G418-resistant clones expressing normal bamacan/SMC3 mRNA
levels did not generate foci of transformation, clones 9 and 22 generated numerous foci of transformation (Fig. 2D).
Moreover, cells expressing normal bamacan level (clone 6) formed a
uniform monolayer, whereas cells overexpressing bamacan exhibited an
haphazard arrangement and lacked contact inhibition (Fig.
2E). In agreement with the Northern blotting data, the
cellular levels of bamacan/SMC3 protein in the overexpressing clones
were ~3-fold higher than control (Fig. 2F). In contrast,
no bamacan levels could be detected in the media conditioned by either
wild type or transfected cells (not shown).
To corroborate the transformation potential of bamacan, we performed
additional experiments in which bamacan/SMC3 gene was delivered into
NIH 3T3 cells using pLXSN retroviral vector. Among 12 clones isolated,
one displayed increased bamacan/SMC3 mRNA (clone 1, Fig.
3A) and protein (Fig.
3B) levels. As in the cells transfected with the
pcDNA3.1 vector, the retroviral clones overexpressing bamacan
formed numerous foci of transformation (Fig. 3C).
Collectively, these findings support the conclusion that induction of
intracellular bamacan/SMC3 expression is sufficient to cause
transformation of normal, contact-inhibited fibroblasts.
Bamacan Expression Is Abnormally Elevated in Colon Carcinoma Cell
Lines and Colon Carcinoma Tissues--
To assess whether the degree of
bamacan/SMC3 expression that caused transformation of 3T3 fibroblast
was similar to that of established neoplastic cells, a series of mouse
and human neoplastic cell lines was examined. A non-tumorigenic colon
epithelial cell line originated from p53 Bamacan Is Overexpressed in Intestinal Tumors of APC-deficient
Min/+ Mice--
There is convincing evidence that most human colon
carcinomas exhibit loss of heterozygosity at the Apc locus
coding for the APC tumor suppressor gene (16). In mice, a non-sense
mutation (Min allele) of the Apc gene causes the
development of multiple intestinal neoplasia (Min/+) (17).
As in humans, the adenomas in Min/+ mice show loss of the
wild type Apc allele. Therefore, we sought to establish
whether bamacan is also overexpressed in adenomas from Min/+
mice. Careful examination of five animals of eight months of age
revealed that all had advanced intestinal neoplasia covering ~60% of
the small intestine. In agreement with the data presented above, there
was a ~4-fold elevation of bamacan/SMC3 expression in the tumors
(Fig. 4, E and F). This elevation was specific
inasmuch as no difference in bamacan/SMC3 mRNA levels was detected
in the proximal or distal colon, or in the testis, when compared with
the levels expressed in the same tissues of sex- and age-matched
Apc +/+ C57BL/6J mice. The increased expression of bamacan
mRNA in the intestinal tumors was confirmed by Western immunoblotting, which showed a ~4-fold increase of bamacan protein in
the neoplastic tissues (Fig. 4G). These findings support the concept that an APC-related pathway may mediate bamacan up-regulation in colon tumors.
The results of this study strengthen the notion that bamacan/SMC3
may play an important role in tumorigenesis (6). The degree of gene
activation that leads to cell transformation in normal mouse cells is
comparable with that observed in a series of colon carcinomas cell
lines and in the majority of human colon carcinoma specimens. The
average 4-fold increase supports the idea that bamacan/SMC3
biosynthesis is tightly regulated in normal cells and that an imbalance
in the amounts of this protein can directly affect the transformation program.
Several functional roles have been assigned to eukaryotic bamacan/SMC3
for which it is possible to envision mechanisms linking its
overexpression to cell growth disregulation. The involvement of this
protein in chromatid cohesion during metaphase points to a first
mechanism (18). The protein is part of the cohesin multimeric protein
complex that prevents the premature separation of sister chromatids
(12). This process occurs in an orderly fashion during anaphase under
the control of the cell cycle machinery and, if improperly executed,
could result in the segregation of both sisters to the same cell
thereby generating an aneuploid karyotype (19). Bamacan/SMC3 is also a
necessary component, together with SMC1, of a multimeric complex
named RC1 that has DNA recombination/renaturation, DNA ligase, and DNA
polymerase activities (13). The enzymes act in concert to repair a
gapped or deleted DNA. These different functions of bamacan/SMC3 are mediated by its ability to bind palindromic DNA sequences through its C
terminus and by allowing the formation of protein-DNA structures that are accessible to the action of DNA-modifying enzymes
(20, 21).
The functional significance of proteoglycan core protein in the nucleus
and at the same time extracellularly eludes a simple interpretation.
Proteoglycans can affect cell growth and differentiation by acting
through different signaling pathways (22). Increased levels of
proteoglycans with altered composition have been reported in human
tumors, primarily those of epithelial origin, such as breast, colon,
and lung. Bamacan proteoglycan has been shown to be a normal
constituent of the basement membranes in several tissues (3) and is,
thus, plausible that its secretion is a physiological event. Whether
abnormal accumulation of extracellular bamacan occurs during tumor
formation and the exact extracellular function of this protein needs to
be established in future studies.
In conclusion, our results support the concept that
overexpression of bamacan/SMC3 alone is sufficient to initiate cell
transformation in normal fibroblasts. Thus, abnormal expression of
bamacan/SMC3 gene may disrupt the formation of the multimeric protein
complexes within the nucleus which could directly contribute to the
genesis of a transformed phenotype.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-helix coiled-coils in an
antiparallel arrangement folded at a flexible hinge (10). The terminal
ends harbor five glycanation sites to which the attachment of
glycosaminoglycan side GAG chains is possible, and a P-loop and a
DA-box motif that may act cooperatively to bind ATP and DNA,
respectively (11). These features and the high sequence homology with
the structural maintenance of chromosome 3 (SMC3)1 protein led us to
conclude that bamacan is a member of this family (6). SMC3 proteins are
involved in the formation of at least two multimeric complexes within
the nucleus. The first, termed "cohesin", is involved in chromosome
cohesion and prevents premature sister chromatid separation (12). The
second, called RC-1, is involved in DNA repair and has DNA ligase and
polymerase activity (13). The formation of a third complex has been
postulated on the basis that bamacan/SMC3 can be co-isolated with
proteins involved in microtubule dynamics (9). Finally, the protein has
a functional leucine zipper domain that binds Mxi and Max, two nuclear
proteins that interact with Myc and modulate its transcriptional
activity (14).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-32P]dATP (~3000
Ci/mmol) and [35S]methionine (~1000 Ci/mmol) were
obtained from Amersham Pharmacia Biotech. The transcription/translation TNT T7 kit was from Promega. Rabbit anti-mouse bamacan/SMC3 antibody was kindly provided by A. Strunnikov. Cell lines include: NIH and
Balb/c 3T3 mouse fibroblasts that display contact inhibition and serum
dependence; a non-tumorigenic colon epithelial cell line originated
from p53
/
mice (15); CMT-93 mouse colorectal carcinoma cells; and
the human colon carcinoma cell lines HCT116, WiDr, SW480, LOVO, and
CaCo2 (American Type Culture Collection). Nineteen human colon
carcinoma specimens and matched normal tissues, and five
Min/+ animals were also investigated.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (24K):
[in a new window]
Fig. 1.
Generation of full-length bamacan expression
vectors and in vitro transcription/translation.
A, schematic representation of the various EST clones and
the RT-PCR generated insert that were sequentially ligated into
pBS-KS+. B, expression vectors constructed by ligating
bamacan/SMC3 cDNA into a myc-His-tagged pcDNA3.1 or pLXSN
retroviral vector. C, autoradiograph of a 7% SDS-PAGE from
the in vitro transcription-translation of the bamacan/SMC3
pcDNA3.1 vector using [35S]methionine as the
precursor. Notice the presence of a ~146-kDa band in lanes
1 and 3, in the presence or absence or protease
inhibitors, respectively. Lane 2 lacks the vector, whereas
lane 4 is the positive control vector harboring the
luciferase gene encoding a ~60-kDa protein.

View larger version (45K):
[in a new window]
Fig. 2.
Overexpression of bamacan/SMC3 causes
transformation of Balb-c 3T3 fibroblasts. A, Northern
blotting of total RNA extracted from clone 6 (a G418-resistant but
lacking bamacan/SMC3 expression) and two overexpressing clones. For
loading comparison, the ethidium bromide-stained ribosomal RNA
(rRNA) is shown in the lower panel. B,
growth in soft agar as determined after 21 days of growth.
C, growth curve of three individual clones as indicated.
D, focus assay of clones as in A. The wild type
was identical to clone 6 (not shown). E, morphological
changes and lack of contact inhibition in cells overexpressing
bamacan/SMC3. F, Western immunoblotting of total cell
extracts (~20 µg of protein each) of clone 6 (lane 1)
and clone 9 (lane 2) using a rabbit antibody raised against
Pro1137-Ser1157 region of murine
bamacan.

View larger version (44K):
[in a new window]
Fig. 3.
Overexpression of bamacan/SMC3 causes
transformation of NIH 3T3 fibroblasts. A, Northern
blotting of five independent G418-resistant clones transfected with
pLXSN retroviral bamacan/SMC3 expression vector. For loading
comparison, the ethidium bromide-stained ribosomal RNA
(rRNA) is shown in the lower panel. B,
Western immunoblotting of bamacan/SMC3 levels (20 µg of cellular
protein) in clone 1, a bamacan overexpressing clone, and clone 2 as
representative of one of 12 clones expressing normal bamacan/SMC3
levels. C, focus assay for clones 1 and 2.
/
mice was used as
control. These cells do not grow in soft agar and do not generate
tumors in either SCID or immunocompetent syngeneic mice (15). Compared
with the expression in this primary colon cell line, a 5-fold increase in bamacan/SMC3 expression was observed inCMT-93 mouse colorectal carcinoma cells (Fig. 4A).
Similar results were obtained when normal colon tissue and the matching
neoplastic tissue from a patient with colon carcinoma were investigated
(Fig. 4B). Five independent human colon carcinoma cell lines
displayed the same degree of bamacan overexpression as the colon
carcinoma sample (Fig. 4B), suggesting that the phenomenon
does not simply reflect the high rate of mitosis of the cells held in
culture. We then compared bamacan/SMC3 expression in matched neoplastic
and normal colon tissues (n = 19). About 70% of the colon
carcinomas displayed a significant increase in bamacan/SMC3 steady
state mRNA levels (Fig. 4C). In the colon carcinomas,
bamacan mRNA levels were 3.7 ± 0.4 (mean ± S.E.) higher
than matched control tissues (p < 0.0002 by paired
Student's t test) (Fig. 4D).

View larger version (32K):
[in a new window]
Fig. 4.
Bamacan expression is abnormally elevated in
colon carcinoma cell lines, human colon carcinoma, and in intestinal
tumors from Min/+ mice. A, Northern
blotting of murine normal colon epithelium and colorectal carcinoma
CMT-93 cell line. The blot was hybridized with a murine
bamacan-specific 32P-labeled cDNA (P144). For loading
comparison, the ethidium bromide-stained ribosomal RNA
(rRNA) is shown in the lower panel. B,
Northern blotting of human colon and colon carcinoma tissues and five
independent colon carcinoma cell lines as indicated. The blot was
hybridized with a human bamacan-specific 32P-labeled
cDNA (P554). C, Northern blotting of representative
human colon (N) and colon carcinoma (T) specimens. D,
quantification of 19 matched samples from normal and neoplastic colon
tissues. Films were scanned with the NIH Scion Image software, which
provides a direct numeric output for the densitometric profiles. Data
are plotted as arbitrary intensity units corrected for the amount of
rRNA. E, Northern blotting of bamacan expression in various
tissues from Min/+ mice. The intestine of 8-month-old
Min/+ mice were dissected under a microscope and the
adenomatous areas carefully separated from normal tissue. Other
collected tissues are as indicated. F, abundance of bamacan
mRNA in the different specimens calculated as relative to the
matching normal small intestine. In E and F,
lanes 1, 3, 5, and 7 represent tissues from a C57BL/6J Apc +/+, whereas
lanes 2, 4, 6, and 8 represent tissues from a Min/+ mouse. The adenomatous tissue
is in lane 2. Samples in lanes 9-12 are from two
Min/+ mice and represent normal (lanes 9 and
11) and adenomatous tissue (lanes 10 and
12). G, Western immunoblotting of two
Min/+ mice (~20 µg of protein each) using anti-bamacan
antiserum. Lanes 1 and 3 represent normal small
intestine, whereas lanes 2 and 4 are the matching
neoplastic tissues.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
| |
ACKNOWLEDGEMENTS |
|---|
We thank I. Eichstetter for excellent technical assistance, A. Strunnikov for the gift of anti-bamacan/SMC3 antiserum, and L. Siracusa for providing the Min/+ mice.
| |
FOOTNOTES |
|---|
* This work was supported by National Institutes of Health Grants RO1 CA39481 and RO1 CA47282 (to R. V. I).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Dept. of Pathology, Anatomy and Cell Biology, Rm. 249, JAH, Thomas Jefferson University, 1020 Locust St., Philadelphia, PA 19107. E-mail: iozzo@lac.jci. tju.edu.
Published, JBC Papers in Press, May 3, 2000, DOI 10.1074/jbc.C000213200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: SMC3, structural maintenance of chromosome protein 3; PAGE, polyacrylamide gel electrophoresis; RT-PCR, reverse transcriptase polymerase chain reaction; bp, base pair(s); PAGE, polyacrylamide gel electrophoresis; EST, expressed sequence tag.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Iozzo, R. V., and Clark, C. C. (1986) J. Biol. Chem. 261, 6658-6669 |
| 2. | Iozzo, R. V., and Clark, C. C. (1987) Histochemistry 88, 23-29 |
| 3. | McCarthy, K. J., Accavitti, M. A., and Couchman, J. R. (1989) J. Cell Biol. 109, 3187-3198 |
| 4. | McCarthy, K. J., Bynum, K. R., St. John, P. L., Abrahamson, D. R., and Couchman, J. R. (1993) J. Histochem. Cytochem. 41, 401-414 |
| 5. | Couchman, J. R., Kapoor, R., Sthanam, M., and Wu, R.-R. (1996) J. Biol. Chem. 271, 9595-9602 |
| 6. | Ghiselli, G., Siracusa, L., and Iozzo, R. V. (1999) J. Biol. Chem. 274, 17384-17393 |
| 7. | Wu, R.-R., and Couchman, J. R. (1997) J. Cell Biol. 136, 433-444 |
| 8. | Stursberg, S., Riwar, B., and Jessberger, R. (1999) Gene (Amst.) 228, 1-12 |
| 9. | Shimizu, K., Shirataki, H., Honda, T., Minami, S., and Takai, Y. (1998) J. Biol. Chem. 273, 6591-6594 |
| 10. | Melby, T. E., Ciampaglio, C. N., Briscoe, G., and Erickson, H. P. (1998) J. Cell Biol. 142, 1595-1604 |
| 11. | Strunnikov, A., and Jessberger, R. (1999) Eur. J. Biochem. 263, 6-13 |
| 12. | Michaelis, C., Ciosk, R., and Nasmyth, K. (1999) Cell 91, 35-45 |
| 13. | Jessberger, R., Podust, V., Hübscher, U., and Berg, P. (1993) J. Biol. Chem. 268, 15070-15079 |
| 14. | Gupta, K., Anand, G., Yin, X., Grove, L., and Prochownik, E. V. (1998) Oncogene 16, 1149-1159 |
| 15. | Sevignani, C., Wlodarski, P., Mercer, E., Danielson, K. G., Iozzo, R. V., and Calabretta, B (1998) J. Clin. Invest. 101, 1572-1580 |
| 16. | Kinzler, K., and Vogelstein, B. (1991) Cell 87, 159-170 |
| 17. | Gould, K., and Dove, W. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 5848-5853 |
| 18. | Darwiche, N., Freeman, L. A., and Strunnikov, A. (1999) Gene (Amst.) 233, 39-47 |
| 19. | Farr, K. A., and Cohen-Fix, O. (1999) Eur. J. Biochem. 263, 14-19 |
| 20. | Akhmedov, A. T., Gross, B., and Jessberger, R. (1999) J. Biol. Chem. 274, 38216-38224 |
| 21. | Moghal, N., and Sternberg, P. W. (1999) Curr. Opin. Cell Biol. 11, 190-196 |
| 22. | Iozzo, R. V. (1998) Annu. Rev. Biochem. 67, 609-652 |
This article has been cited by other articles:
![]() |
S. K. Olson, J. R. Bishop, J. R. Yates, K. Oegema, and J. D. Esko Identification of novel chondroitin proteoglycans in Caenorhabditis elegans: embryonic cell division depends on CPG-1 and CPG-2 J. Cell Biol., June 19, 2006; 173(6): 985 - 994. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Assmann, M. R. Alborghetti, M. E. R. Camargo, and J. Kobarg FEZ1 Dimerization and Interaction with Transcription Regulatory Proteins Involves Its Coiled-coil Region J. Biol. Chem., April 14, 2006; 281(15): 9869 - 9881. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Bard, J. P. Hegmans, A. Hemmes, T. M. Luider, R. Willemsen, L.-A. A. Severijnen, J. P. van Meerbeeck, S. A. Burgers, H. C. Hoogsteden, and B. N. Lambrecht Proteomic Analysis of Exosomes Isolated from Human Malignant Pleural Effusions Am. J. Respir. Cell Mol. Biol., July 1, 2004; 31(1): 114 - 121. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lara-Pezzi, N. Pezzi, I. Prieto, I. Barthelemy, C. Carreiro, A. Martinez, A. Maldonado-Rodriguez, M. Lopez-Cabrera, and J. L. Barbero Evidence of a Transcriptional Co-activator Function of Cohesin STAG/SA/Scc3 J. Biol. Chem., February 20, 2004; 279(8): 6553 - 6559. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-F. Lambert, M. Liu, G. A. Colvin, M. Dooner, C. I. McAuliffe, P. S. Becker, B. G. Forget, S. M. Weissman, and P. J. Quesenberry Marrow Stem Cells Shift Gene Expression and Engraftment Phenotype with Cell Cycle Transit J. Exp. Med., June 2, 2003; 197(11): 1563 - 1572. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ghiselli, N. Coffee, C. E. Munnery, R. Koratkar, and L. D. Siracusa The Cohesin SMC3 Is a Target the for {beta}-Catenin/TCF4 Transactivation Pathway J. Biol. Chem., May 23, 2003; 278(22): 20259 - 20267. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Carson and M. F. Christman Evidence that replication fork components catalyze establishment of cohesion between sister chromatids PNAS, July 17, 2001; 98(15): 8270 - 8275. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |